RNA-based Therapeutics and Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

  • Single User License $3500

RNA-based Therapeutics and Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

Status : September, 2020 | Biotechnology | PPT format

Report Digest


Global RNA-based Therapeutics and Vaccines Market: Overview

RNA-based biopharmaceuticals is a comparatively new class of treatment and it comprises vaccines and therapeutics. These biopharmaceuticals are prophylactic medicines that are used in the treatment of various rare and chronic diseases, which includes certain cardiovascular conditions, tuberculosis, diabetes, and cancer. The main objective of RNA therapeutics is to invent a cure for rare diseases and various unmet clinical conditions. This field is research-based and advancement made in the field of technology is likely to expand the global RNA-based therapeutics and vaccines market over the tenure of assessment.

Development of various promising technologies such as RNAi interference technology, SMaRT technology, and antisense technology are likely to offer promising growth opportunities for the global RNA-based therapeutics and vaccines market in the years to come.

The global RNA-based therapeutics and vaccines market has been classified based on product type, indication type, and region. The main objective of providing such a comprehensive report is to provide a deep insight into the market.

Global RNA-based Therapeutics and Vaccines Market: Notable Developments

The global RNA-based therapeutics and vaccines market has come across some path-breaking developments in the last few years. One of such developments shaping the course of the market is mentioned below:

  • In 2018, US-based Alnylam Pharmaceuticals, Inc and Regeneron Pharmaceuticals, Inc. have entered into a strategic collaboration to come up with RNAi therapeutics for the purpose of treatment of non-alcoholic steatohepatitis (NASH), a chronic liver disease.

Some of the key market players of the global RNA-based therapeutics and vaccines market are

  • Arrowhead Pharmaceuticals, Inc.
  • Moderna Therapeutics, Inc
  • Marina Biotech, Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Arbutus Biopharma Corp.
  • Santaris Pharma A/S (A Roche Company)

Global RNA-based Therapeutics and Vaccines Market: Growth Drivers

Presence of Large of Patients with Infectious and Chronic Diseases to Generate Demand

The growth of the global RNA based therapeutics and vaccine market is likely to be influenced by the demand to find cure for infectious diseases and cancer. In addition, the pool of patient is very large, which is likely to emerge as another growth factor for the global RNA based therapeutics and vaccine market in the forthcoming years. The shortage of availability of alternative options of treatment for very rare diseases is likely to boost the demand for RNA-based therapeutics and vaccines over the period of analysis. Besides, augmented emphasis on the development of reimbursement policies by legislative bodies has triggered the development process of molecules of RNA.   

Various non-profit organizations have made substantial financial investment for the advancement and development of RNA therapeutics. The rising demand for therapeutics in the treatment of various unmet medical conditions is likely to bolster growth of the global RNA based therapeutics and vaccine market in the years to come. On the other hand, high rates of failure and high cost involved with the research are expected to restrict development of the global RNA based therapeutics and vaccine market over the period of analysis.

Global RNA-based Therapeutics and Vaccines Market: Regional Outlook

Of all the regions that have been analyzed in the report, North America is estimated to account for the most of the share in the global RNA based therapeutics and vaccine market. The growth of the region is ascribed to the high adoption rate of latest technologies. Besides, increased prevalence of various chronic diseases in North America is likely to augur well for the regional market in the times to come.

Asia Pacific is likely to emerge as another highly lucrative region in the global RNA based therapeutics and vaccine market. Substantial investment being made by government authorities for the development of the market in the years to come, which is likely to drive the demand in the region. 

The global RNA-based Therapeutics and Vaccines market is segmented as:

Product Type

  • RNA-based Therapeutics
  • RNA-based Vaccines

Indication Type

  • Oncology
  • Immunology
  • Ophthalmology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Genetic Diseases

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?